Gentamicin administration on the stapes footplate causes greater hearing loss and vestibulotoxicity than round window administration in guinea pigs.

Simple item page
dc.contributor.authorKing, Elisha
dc.contributor.authorSalt, Alec
dc.contributor.authorKel, Gordana
dc.contributor.authorEastwood, Hayden
dc.contributor.authorO'Leary, Stephen
dc.date.accessioned2013-11-15T04:48:40Z
dc.date.available2013-11-15T04:48:40Z
dc.date.issued2013-10
dc.description.abstractClinically, gentamicin has been used extensively to treat the debilitating symptoms of Mèniére’s disease and is well known for its vestibulotoxic properties. Until recently, it was widely accepted that the round window membrane (RWM) was the primary entry route into the inner ear following intratympanic drug administration. In the current study, gentamicin was delivered to either the RWM or the stapes footplate of guinea pigs (GPs) to assess the associated hearing loss and histopathology associated with each procedure. Vestibulotoxicity of the utricular macula, saccular macula, and crista ampullaris in the posterior semicircular canal were assessed quantitatively with density counts of hair cells, supporting cells, and stereocilia in histological sections. Cochleotoxicity was assessed quantitatively by changes in threshold of auditory brainstem responses (ABR), along with hair cell and spiral ganglion cell counts in the basal and second turns of the cochlea. Animals receiving gentamicin applied to the stapes footplate exhibited markedly higher levels of hearing loss between 8 and 32 kHz, a greater reduction of outer hair cells in the basal turn of the cochlea and fewer normal type I cells in the utricle in the vestibule than those receiving gentamicin on the RWM or saline controls. This suggests that gentamicin more readily enters the ear when applied to the stapes footplate compared with RWM application. These data provide a potential explanation for why gentamicin preferentially ablates vestibular function while preserving hearing following transtympanic administration in humans.en_US
dc.description.sponsorshipA.S was supported by NIH/NIDCD grant DC01368, project was supported by NHMRC 509206, the Garnett Passe and Rodney Williams Memorial Fund.en_US
dc.identifier.citationKing, E. B., Salt, A. N., Kel, G. E., Eastwood, H. T., & O’Leary, S. J. (2013). Gentamicin administration on the stapes footplate causes greater hearing loss and vestibulotoxicity than round window administration in guinea pigs. Hearing Research (304). p159-166.en_US
dc.identifier.urihttp://repository.bionicsinstitute.org:8080/handle/123456789/61
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.titleGentamicin administration on the stapes footplate causes greater hearing loss and vestibulotoxicity than round window administration in guinea pigs.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2014-11 King HearRes GentamicinVestibulotoxicity.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
BI publications